DOI:
10.1055/s-00029025
Journal of Pediatric Epilepsy
LinksClose Window
References
Rose K, Fumi L, Grant-Kels JM.
Reader response: clinical trials of disease-modifying agents in pediatric MS: opportunities, challenges, and recommendations from the IPMSSG.
Neurology 31 May 2019. Available at:
https://n.neurology.org/content/reader-response-clinical-trials-disease-modifying-agents-pediatric-ms-opportunities
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.